Twist Bioscience Corporation Common Stock — Grafico, Quotazione e Notizie (NASDAQ:TWST)

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 3.52 B
Employee 979
Founded 2013
CEO Emily LeProust
Website www.twistbioscience.com
Headquarter Delaware, United States
FIGI BBG006KDCHJ4
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

3.52 B Capitalizzazione di mercato

Rapporto prezzo/utili

-21.65

Rapporto prezzo/fatturato

4.47

Twist Bioscience Corporation

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.